Rozanne C. de Veer

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

Maren H. Harms, Rozanne C. de Veer, Willem J. Lammers et al. · Gut · 2019 · 46 citations · Full text

Medicine, Pharmacotherapy, Surgery +12

Liver transplant‐free survival according to alkaline phosphatase and <scp>GLOBE</scp> score in patients with primary biliary cholangitis treated with ursodeoxycholic acid

Rozanne C. de Veer, Maren H. Harms, Christophe Corpechot et al. · Alimentary Pharmacology & Therapeutics · 2022 · 25 citations · Full text

Medicine, Internal Medicine, Surgery +12

Real‐life study of safety of thiopurine‐allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment

Joany E. Kreijne, Rozanne C. de Veer, Nanne K.H. de Boer et al. · Alimentary Pharmacology & Therapeutics · 2019 · 22 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Ursodeoxycholic Acid Treatment–Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis

Rozanne C. de Veer, Maria C. van Hooff, Christophe Corpechot et al. · The American Journal of Gastroenterology · 2022 · 18 citations · Full text

Medicine, Internal Medicine, Surgery +15